London: The new type of drugs for type 2 diabetes — SGLT2 inhibitors — are associated with a reduced risk of heart failure by 34 per cent, researchers said. The new SGLT2 inhibitors, which are now a commonly used drug group, reduce blood glucose, they ...
from Google Alert - health https://ift.tt/32lmYWL
via IFTTT
0 comments:
Post a Comment